Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
intrahepatic cholestasis
MeSH D002780 - intrahepatic cholestasis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D008107:
Liver diseases
2 Companies
2 Drugs
$
Success rate
D002779:
Cholestasis
1 Company
1 Drug
$
Success rate
D002780:
Intrahepatic cholestasis
1 Company
1 Drug
$
Success rate
D008105:
Biliary liver cirrhosis
37 Companies
5 Drugs
$
Success rate
D016738:
Alagille syndrome
1 Company
1 Drug
$
Success rate
Events Timeline
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Albireo Pharma
Odevixibat
Bylvay
2021-07-16
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/0
Phase 2
83
%
5/6
Phase 3
14
%
1/7
Approved:
1
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Albireo Pharma
Odevixibat
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use